Today, we review comments by wordsmith Rob Michael, CFO of AbbVie, and his bullish outlook on recently acquired Botox during COVID-19
Share this post
UEC - February 22nd, 2022
Share this post
Today, we review comments by wordsmith Rob Michael, CFO of AbbVie, and his bullish outlook on recently acquired Botox during COVID-19